Immunocytochemically detected free peritoneal tumour cells (FPTC) are a strong prognostic factor in gastric carcinoma

por Nekarda, H, Geß, C, Stark, M, Mueller, J D, Fink, U, Schenck, U, Siewert, J R
Publicado 1999

Phase II study of gemcitabine in patients with advanced pancreatic cancer.

por Carmichael, J., Fink, U., Russell, R. C., Spittle, M. F., Harris, A. L., Spiessi, G., Blatter, J.
Publicado 1996

Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer

por Schneider, P M, Praeuer, H W, Stoeltzing, O, Boehm, J, Manning, J, Metzger, R, Fink, U, Wegerer, S, Hoelscher, A H, Roth, J A
Publicado 2000